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Segmental copy-number variations (CNVs) may contribute to genetic variation in humans. Reports of the existence and
characteristics of CNVs in a large Japanese cohort are quite limited. We report the data from a large Japanese population. We
conducted population screening for 213 unrelated Japanese individuals using comparative genomic hybridization based on a
bacterial artiﬁcial chromosome microarray (BAC-aCGH). We summarize the data by focusing on highly polymorphic CNVs
in ≥5.0% of the individual, since they may be informative for demonstrating the relationships between genotypes and their
phenotypes. We found a total of 680 CNVs at 16 diﬀerent BAC-regions in the genome. The majority of the polymorphic CNVs
presented on BAC-clones that overlapped with regions of segmental duplication, and the majority of the polymorphic CNVs
observed in this population had been previously reported in other publications. Some of the CNVs contained genes which might
be related to phenotypic heterogeneity among individuals.
1.Introduction
Segmental copy-number variations (CNVs), involving the
gain or loss of several hundreds of bases to several hun-
dred kilobases (kb) of the genome, can be an important
source of genetic variation among human populations of
diﬀerent ethnic groups as well as among individuals. This
heterogeneitymaycontributetonoted phenotypicvariations
and diﬀerent susceptibilities to various diseases. Molecular
genetics analyses and cytogenetic analyses have provided
signiﬁcant information about these variations in the human
genome, speciﬁcally as they relate to disease, such as cancer,
and to congenital malformation (see [1, 2], and review
in [3]). Following the development of methodologies and
the introduction of new research platforms [4–9], infor-
mation regarding the nature and pattern of CNVs from
representative populations have accumulated. Examinations
of a relatively large number of individuals from various
speciﬁc ethnic groups have recently been conducted using
diﬀerent array platforms, such as BAC-arrays [10–13], oligo-
arrays [14–16], and others [17] .T h er e s u l t sa r en o ta l w a y s
consistent and it is likely that diﬀerent human populations
bear diﬀerent CNVs. The numbers of Japanese individuals
examined to date are not so large compared to the studies
for other ethnicities [18]. Polymorphic CNVs have received
considerable attention since they might play an important
role in the etiology of common diseases. Therefore, more
data regarding CNVs should be accumulated from Japanese
populations. In this report, we focus on CNVs which were
observed at a high frequency (≥5.0% of the individuals) in
the population residing in Hiroshima and Nagasaki, Japan
by aCGH with BAC-clones as targets.
2.Materialsand Methods
In the study, the population studies were conducted at two
stages: Stage (1): 80 unrelated Japanese individuals were
examined using BAC-aCGH with an array having 2,241 BAC2 Journal of Biomedicine and Biotechnology
clones, and Stage (2): 133 unrelated Japanese individuals
were examined using BAC-aCGH that contained 2,622 BAC-
clones.
2.1. Target BAC-Clones Preparation. The majority of the
clones used in Stage (1) of this study were selected from
the set of cytogenetically mapped P1-artiﬁcial chromosome
(PAC) clones and bacterial artiﬁcial chromosome (BAC)
clones reported by the BAC Resource Consortium [19]
and obtained from either the Children’s Hospital Oakland
Research Institute (Oakland, CA, USA) or from Invitrogen
Inc., Co. (Carlsbad, CA, USA). In Stage (2), in addition to
BAC clones used in Stage (1), an additional 381 BAC clones
were used, a majority of which were collaboratively obtained
from Dr. N. Matsumoto of Yokohama City University. The
2,241 clones of chromosomal fragments from chromosome
1 to chromosome 22 were used in Stage (1) and 2,622 clones
were used in Stage (2), respectively. That is, the additional
381 BAC clones were examined for only 133 unrelated
individuals in Stage (2). Those clones are distributed every
1.2Mb across all of the human autosomes in Stage (1), and
1.1Mb in Stage (2), respectively. In addition to autosomal
clones, four kinds of X-chromosomal clones were used as
internal references. With respect to examination for Stage
(1), three sets of arrays were constructed and imprinted:
slide no.1, consisted of 698 clones on chromosomes 1 to 4;
slide no.2 consisted of 718 clones on chromosomes 5 to 10,
plus two BAC clones on chromosome 3, and six clones on
chromosome 4; and slide no.3 consisted of 817 clones on
chromosomes 11 to 22 [20]. For Stage (2), all of the clones
were printed onto one glass slid.
2.2. Genomic DNA Samples. The genomic DNA samples
used in this study were principally the same as those used in
ap r e v i o u ss t u d y[ 20]. The DNA samples used for reference
purposes were extracted from mononuclear cells of two
physically and clinically normal volunteers (a 57-year-old
Japanese male and a 54-year-old Japanese female). The DNA
used for testing and analyses of this populationwas extracted
from lymphoblastoid cell lines obtained from the oﬀspring
of atomic-bomb survivors. High molecular weight genomic
DNA was isolated using conventional methods as described
in detail elsewhere [21]. Lymphoblastoid cell lines were
derived from a cryopreserved archive of approximately 1000
families consisting of father, mother, and oﬀspring from
Hiroshima and Nagasaki for whom permanent cell lines have
been established by Epstein-Barr (EB) virus transformation
of peripheral B-lymphocytes. The composition of the fam-
ilies has been reported elsewhere [22]. Three hundred ﬁve
oﬀspring were initially screened. Since the oﬀspring include
some siblings, we selected one representative oﬀspring to
construct “unrelated individuals” to avoid double counting
of polymorphic CNVs from families containing two or more
siblings. We selected the oﬀspring who ﬁrst visited our
institution for donating blood rather than other siblings.
The 213 oﬀspring selected as unrelated individuals included
124 oﬀspring from Hiroshima and 89 from Nagasaki. The
individuals gave their informed consent prior to the study.
The Institutional Review Board of our Foundation approved
this study.
2.3. Array Preparations. ClonedDNAsformicroarray targets
were isolated from bacterial cultures using NucleoBond
BAC 100 (NIPPON Genetics, Tokyo). With respect to
Stage (1), DNA was digested by NotI followed by phenol-
chloroform-isoamyl alcohol (25:24:1) extraction and
ethanol-precipitation. On the other hand, in Stage (2),
cloned DNA was digested with MseI followed by phenol-
chloroform-isoamyl alcohol (25:24:1) extraction and
ethanol precipitation. The fragmented DNAs were ampliﬁed
by ligation-mediated PCR carried out as described by
Snijders et al. [23]. The target DNAs (0.5μg/μL) were
dissolved in 50%-dimethylsuloxide and printed in triplicate
onto the glass slides (Matsunami Glass Co. Ltd.) using the
Aﬀymetrix 417 Arrayer (Aﬀymetrix).
2.4. Array-CGH Analysis
2.4.1. Screening by the Array CGH Method. The screenings
of both stages were conducted following the procedures
describedpreviously[20].Inbrief,forlabelingDNA,testand
reference genomic DNA (1.25μge a c h )w a sc u tb yBamHI,
and labeled by a random priming method with Cyanine-
5- and Cyanine-3-labeled dUTP (Cy5- and Cy3-dUTP;
PerkinElmer Life Sciences, Wellesley, MA, USA). The labeled
probes were mixed and centrifuged with Microcon column
(Millipore Co., Bedford, MA, USA) to purify the probes.
Subsequently, human CotI DNA (120μg; Roche Diagnostic
GmbH, Mannheim, Germany) was added to the column,
and recentrifuged. After the volume of the mixture became
less than 20μL, it was transferred to microtubes with 100μL
of hybridization solution (50% formamide, 10% dextran
sulfate, 1% Tween 20, 2 × S S C ,1 0 m MT r i s - H C l[ p H7 . 4 ]
and 800μg of yeast t-RNA[Invitrogen, Carlsbad, CA,USA]).
The hybridizationmixturewasthendenaturedat70◦Cf or10
minutes, and subsequently incubated at 37◦C for at least ﬁve
hours to block repetitive sequences of the labeled probes.
Prehybridization was conducted in order to block repet-
itive sequence binding of target DNA on the arrays, and to
prevent nonspeciﬁc binding of probe DNA to the targets.
Following the initial incubation (overnightat 37◦C),the pre-
hybridization solution was removed, and fresh hybridization
solutionwith Cy-labeledDNA(prepared asdescribedabove)
was added. Again, hybridization processes were carried out.
The prehybridization and the hybridization were conducted
with continuous mixing. After hybridization, the arrays
were washed by the procedures reported previously [20].
All of the procedures were conducted using the GeneTAC
Hybridization Station (Genomic Solutions Inc., Ann Arbor,
MI, USA).
2.4.2. Imaging and Data Management. Fluorescentimages of
the hybridized arrays were obtained using a ScanArray 5000
confocal laser scanner (PerkinElmer Life Sciences). Array-
Suite (Scanalytics Inc., Fairfax, VA, USA) in Stage (1) and
Gene Pix (Axon Instruments, Sunnyvale, CA) in Stage (2),Journal of Biomedicine and Biotechnology 3
respectively, were used to quantify the ﬂuorescence of each
spot on the array images. We then used software speciﬁcally
developed to perform the following three measurements.
(1) Fluorescentratios ofthe totalintegrated Cy3and Cy5
intensities for each target (triplicate spots for each
target) were calculated, along with the mean ratios
of the triplicate spots (if the raw ratio of one of the
triplicate spots diﬀered by more than 10% from the
othertwo, the value was automatically excludedfrom
the mean ratio calculation).
(2) Normalized ratios were computed by dividing each
raw ratioby themean raw ratiosofeveryautosomally
mapped target (therefore, after normalization, the
averaged ratio for all targets in one array was 1.0).
(3) The spots whose ratios were 2.58 standard deviations
(SD) below the mean (1.0), or 2.58 SD above the
mean, were marked “CNV.” To conﬁrm the quality
of each analysis, the ratio of X-linked clones was
veriﬁed.
2.4.3. Pulse Field Gel Electrophoreses. EB-transformed lym-
phoblastoid cells established from the oﬀspring were embed-
ded in agarose plugs. DNA in the plugs was cleaved
by restriction enzymes (PacI, or Sse8387I). The resulting
fragments were then separated by pulse ﬁeld gel elec-
trophoreses (PFGE) on 1% Pulse Field Certiﬁed Agarose
(BioRad, Hercules, CA, USA) with × 0.5 TBE (Tris-Borate-
Ethylenediaminetetraacetic acid). Using the CHEF-DR II
system (BioRad) [24], electrophoresis was carried out using
6V/cm at 14 ◦C for 22hrs. The angle of pulse was 120◦.
T h es w i t c ht i m ew a su s e d :r a m p e df r o m0 . 3s e c o n d st o1 5
seconds.
2.4.4. Southern Blotting and Hybridization. Southern blot
analyses were carried out using conventional, well-described
procedures [25]. In brief, after completion of PFGE, the
DNA in the gel was cleaved by UV irradiation and blotted
onto nitrocellulose ﬁlters (Schleiche & Schuell, Dassel,
Germany). The ﬁlters were prehybridized with human CotI
DNA(48μg/ml, Roche Diagnostic GmbH) and salmon testis
DNA (14μg/ml, Sigma-Aldrich) to decrease the background
due to repetitive sequences. Subsequently, the ﬁlters were
hybridized with whole BAC-DNA as a probe. DNA probes
were labeled with [α-32P] dCTP (Amersham Biosciences,
Piscataway, NJ, USA) and preannealed with human CotI
DNA and salmon testis DNA (10.5μg/ml). Prehybridization
and hybridization were performed overnight at 37◦Ci na
solution containing 50% formamide, 10% dextran sulfate,
1% Tween 20, 2 × SSC, and 10 mM Tris-HCl (pH 7.4). After
hybridization, the ﬁlterswere washed at 65◦Cwi t h1 . 0× SSC
containing 0.1% SDS (Sodium dodecyl sulfate) and 0.5 ×
SSC containing 0.1% SDS. Banding patterns were obtained
by either exposure to X-ray ﬁlm (Fuji Film, Tokyo, Japan) or
through use of the Molecular Imager FX (BioRad).
2.4.5. The Procedure of Quantitative Polymerase Chain
Reaction (qPCR). The qPCR was performed using SYBR
premix EX Taq (Takara-Bio) and the Light Cycler Sys-
tem (Roche Diagnostics), according to the manufacturers’
protocols. Primers were designed with Primer3 software
(http://primer3.sourceforge.net), and the size of PCR prod-
ucts was conﬁrmed by the pattern of restriction enzyme
digested fragments using the LabChip DNA 500 Kit on the
2100 Bioanalyzer (Agilent Technologies, Waldbronn, Ger-
many). Two, 0.5, and 0.125ng ofgenome DNAfrom an indi-
vidual with CNV were used and the quantiﬁcation of each
amplicon was carried out at 45 cycles of PCR. The results
were analyzed with Light Cycler Data Analysis software
using a second derivative maximum model. Relative DNA
content of variants for every amplimer was calculated using
“normals” (individualswho didnothaveCNVs) asacontrol.
3.Results
3.1. Population Study. We examined 213 unrelated indi-
viduals. The main purpose of this paper is to report the
accumulation of the data about highly polymorphic CNVs
found in ≥5.0% of the individuals. (The number of CNVs
was 11 or more in each BAC-spot.) As shown in Table 1, 680
polymorphic CNVs were observed on 16 BAC-regions. As
described before, the results of two BAC (RP11-259N12 and
RP11-121A8) were obtained from 133 unrelated individuals
examined in Stage (2).
3.2. Southern Blot Analysis Followed by Pulse Field Gel
Electrophoreses. Southern blot analyses followed by PFGE
werecarriedoutforthehighlypolymorphicCNVs.Asshown
by the typical cases in Figures 1 and 2, the highly polymor-
phic CNVs exhibited complicated patterns of alternation.
The patterns of these two BAC clones (RP11-79F15 and
RP11-88L18) are shown in Figures 1 (RP11-79F15) and 2
(RP11-88L18) as the typical examples. Since each individual
contained a diﬀerent number of core segmental duplica-
tion units, each individual showed bands having diﬀerent
motilities. The numbers of repeat units corresponded to
the intensity of each spot. The data described in the ﬁgure
legends in more detail.
3.3. The qPCR Analysis of CNVs Detected on Two BAC Clones.
The results of qPCR conducted for two BAC clone regions
are described in Figure 3 (RP11-89B15) and Figure 4 (RP11-
79O18). For the former case, a part of a gene (MEOX2)w a s
deleted. On the contrary, for the lattercase, the copy number
of a part of the gene (NSF) increased, but the copy number
o ft h eg e n e( WNT3) did not change.
3.4. Comparing Our Data with Published Data. There
are many segmental duplications which have already
been summarized in a public data base, such as Human
Genome Segmental Duplication Database (TCAG Database;
http:// projects.tcag.ca/cgi-bin/variation/gbrowse), UCSC
Human Genome Browser (UCSC Database; http:/genome
.ucsc.edu/index.html), and NCBI Map Viewer (NCBI Data-
base; http://www.ncbi.nlm.nih.gov/mapview/map search
.cgi). The known CNVs have also been reported in the same4 Journal of Biomedicine and Biotechnology
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Figure 1: (a) Typical patterns of CNVs detected on the BAC clone (RP11-79F15) from Southern blot analyses after PFGE. (b) The Genome
Map from the UCSC genome Browser. (a) The ﬁgure illustrated the pattern from three individuals showing gain on the array and one
showingnormalonthearray.Whenthefragmentlengthofthe“Gain” (lanes;1,3,4)wascomparedwith“Normal”(lane2),thesegmentsizes
of the three (lanes; 1, 3, 4) individuals were larger than those (shown by arrows) of “Normal.” As shown in (b), ﬁve segmental duplications
existed at the 5 -region of the BAC clone. That is, as these three (lanes; 1, 3, 4) contained a larger number of core segments (shown by blocks
in (b)), the signals on the BAC spot were stronger than normal. So, those three were identiﬁed as “Gain.”
databases as above. The CNV data obtained in our studies
are summarized in Table 1 in addition to the presence or
absence of CNVs already reported in the databases. One
BAC clone, named “RP11-115G22,” was mapped on two
chromosomes, 6 and 15 in TCAG Database, so it is likely
that this clone is present on two discrete chromosomes.
On the contrary, however, that clone was mapped on only
Chromosome no.15 in UCSC Database and NCBI Database.
We accept the reports from the latter two databases and
described that this clone was mapped on only Chromosome
no.15. With respect to segmental duplications, 10 out of 16
(about 63%) were present in the above databases (UCSC
Database, and NCBI Database). It was noteworthy that the
majority of BAC clones containing our CNVs were known
to overlap to at least one CNV reported in the database.
However, that does not mean that our highly polymorphic
CNVs are exactly the same as those reported in previous
reports, since precise comparisons between our study and
the other studies were not carried out.
3.5. Comparing Our Data and the Data of Japanese Published
by Redon et al. [18]. As mentioned before, there was very
little information about the CNVs of 45 Japanese individuals
for which relatively large sizes of population have been
systematically screened. We compared our data with the
data of Japanese including the HapMap project as reported
by Redon et al. [18], in which CNVs were examined by a
tiling BAC-array. The results are summarized in Table 1.T e n
out of 16 CNVs identiﬁed in our study were reported in
the data reported by Redon et al. [18], although we should
emphasize again that the CNVs identiﬁed in our BAC region
are not exactly the same as those reported by Redon et al.
[18]. CNVs identiﬁed in our study with lower numbers tend
to not be identiﬁed in Redon’s report [18]. On the otherJournal of Biomedicine and Biotechnology 5
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Figure 2: Typical patterns of CNVs detected on the BAC clone
(RP11-88L18) from Southern blot analyses after PFGE. Very
complicated segmental duplication patterns are present in the
region of this BAC clone. The electrophoresis pattern showed the
complicatedpatternsaccordingtothesegmentalduplication.When
thefragmentlengthofthe“Gain”(lanes;1,2,4)wascomparedwith
“Normal” (lane 3), the segment sizes of the three (lanes; 1, 2, 4)
individuals were larger than those (shown by arrows) of “Normal.”
That is, as those three contained a larger number of core segments,
the signals on the BAC spot were stronger than normal. So, those
three were identiﬁed as “Gain.”
hand, when our data are compared with Redon’s oligo-data
from Aﬀymetrix 500EA array conducted for Japanese, only
two CNVs were overlapped to our CNVs. As Redon et al.
mentioned in their report [18], the reason appears to be that
oligoarrayshavesomelimitationsforacomplicatedgenome,
such as segmental duplication areas.
3.6. Genes and Disease-Related Genes Listed in OMIM
(Online Mendelian Inheritance in Man) (http://www.ncbi
.nlm.nih.gov/omim). We summarized the genes and disease-
related genes in OMIM which overlap to the BAC-clone
region with our CNVs (Table 2). In addition to those two
categories, mRNAs have been also reported in the database,
but they are too many to describe here. All BAC-clone
regionscontainedatleastonemRNA,althoughthefunctions
of a majority of those mRNAs are not known yet (data not
shown).
4.Discussion
We examined 213 unrelated Japanese using BAC-aCGH and
found a totalof680CNVson16BACclones.A largefraction
of the regions involved in the CNVs observed in our study
(i.e., 625 out of 680 (92%), Table 1) have been reported
previously in other studies listed in the database. That sug-
gests that the structural rearrangements are evolutionarily
ancient. Amajority (≈ 63%)of theCNVs had been found on
the BAC clones that overlapped with segmental duplication,
suggesting the notion that segmental duplication might play
a signiﬁcant role in the creation of CNVs (Table 1). The
observations are supported by previous data from Sharp
et al. [11] in which they reported the sharing of CNVs
among several populations, meaning those speciﬁc genomic
imbalances either predated the dispersal of modern humans
outof Africaor aroseindependentlyin diﬀerentpopulations.
On the other hand, the data from Japanese are limited
to about 45 individuals from the HapMap study [18].
We compare our CNVs data to the Japanese data from
Redon et al. [18]. Our CNVs, especially those showing high
frequencies, were also identiﬁed by Redon’s work [18]. On
the contrary, our CNVs showing low frequency, such as less
than about 10% of individuals, were not observed in their
work (Table 1). That result suggests that those CNVs might
beidentiﬁedifthenumberofindividualsexaminedbyRedon
et al. were increased to the level of our study (about 200
individuals). Moreover, as described before, when our data
compared with Redon’s oligo-data conducted for Japanese,
onlytwooftheirCNVswereoverlappedtoourCNVs. Redon
et al. [18] suggested that BAC- and oligo-based methods
complement each other. Although the oligo-based method
tends to detect smaller CNVs (about a few kilobases), this
approach is less eﬀective in tracking CNVs in genomic
regions of complex structure, like segmental duplications,
that are not suﬃciently tagged by oligo targets. On the
contrary, the BAC platform can only identify larger CNVs
(>40kb), but this method has some advantage for detecting
CNVs present in the regions of segmental duplications.
The CNVs in the human genome are often associated
with developmental disorders and susceptibility to diseases.
More importantly, CNVs may represent a major genetic
component of our phenotypic diversity. Large duplications
and deletions have been known to be present within the
humangenomebasedinitiallyoncytogeneticobservationsin
the course of etiological studies of congenital malformations
(e.g., [1, 2]). The frequency of those duplications and
deletions was presumed to be low and, for the most part,
directly related to speciﬁc genetic disorders. A limited
number of studies reported the presence of speciﬁc large
duplications and deletions that were not apparently related
to diseases (e.g., [26]).
Pinkeletal.[4]reportedthatCGHonaBAC-DNA-based
microarray could reliably detect single-copy gene decreases
or increases from normal diploidy. Following this, other
array platforms, such as cDNA [6], and oligo-nucleotide
[11], have been developed and many data from them have
been reported.
As we mentioned before, many CNVs were reported
to be closely related to disease phenotypes, and recent
studies based on advanced molecular technologies, such as
genomewideassociationstudies[27–29]andnextgeneration
sequencing [30, 31], reported that many genes appear to
play important roles in the etiology of common diseases. We
report our highly polymorphic CNVs in BAC clones, which
were reported to contain genes, expected to be related to
phenotypic heterogeneity of each individual, based on the6 Journal of Biomedicine and Biotechnology
Table 1: Summary of highly polymorphic CNVs detected.
Clone number Chrom.
Number
Position
(Mb)
Variant% Known (K)
or Novel (N)$
Segmental
Duplication∗
Data of Redon
Gain Loss [18]#
RP11-259N12 1 103.8 10 48 K P P
RP11-89B17 2 132.1 24 0 K P P
RP11-11M9 4 19.1 0 15 N A A
RP11-231J7 4 158.7 0 23 N A A
RP11-88L18 5 17.5 28 33 K P P
RP11-90A9 5 79.9 57 3 K P A
RP1-299C21 6 103.8 4 79 K A P
RP11-121A8 7 38.0 13 0 K P A
RP11-89B15 7 15.4 0 17 N A A
RP11-90G23 8 86.7 0 51 K P P
RP11-95J4 9 112.9 11 0 K A P
RP11-100C24 13 56.6 38 22 K P P
RP11-115G22 15 30.3 72 0 K P P
RP11-79O18 17 42.1 26 0 K P P
CTD-2100F13 18 19.3 14 0 K A A
RP11-79F15 19 8.7 85 7 K P P
%Number of individuals with CNVs.
$Known (K). The CNVs are already known by the published reports. Novel (N), The CNVs are not reported previously.
∗P: Present, A: Absent. P means that the presence of segmental duplications are reported in the “Database of Genomic Variants” made by The Centre for
Applied Genomics, or A means that those are not reported in the database.
#P means that our CNVs present in BAC-array data from Redon et al. [18]. A means that the CNVs absent in the data.
Table 2: Genes or disease gene (OMIM∗) in BAC clones with highly polymorphic CNVs.
Clone number Genes OMIM
RP11-89B17 CCDC74A, AC093838, POTEK
RP11-88L18 AC106774
RP11-90A9 ANKRD34B, DHFR, SSU rRNA 5, AC008434,
MSH3
(i) DIHYDROFOLATE REDUCTASE; DHFR
(ii) MutS
RP1-299C21
RP11-89B15 MEOX2, AC005550
RP11-90G23 REXO1L2P, AC232323
RP11-95J4
RP11-100C24 PRR20A, PRR20B,
PRR20C, PRR20D, PRR20E
RP11-115G22 CHRNA7
CHOLINERGIC RECEPTOR, NEURONAL
NICOTINIC, ALPHA POLYPEPTIDE 7;
CHRNA7
RP11-79O18 NSF, WNT3
WINGLESS-TYPE MMTV
INTEGRATION SITE FAMILY,
MEMBER 3; WNT3
RP11-79F15 ZNF558, MBD3L1, AC008734
RP11-259N12 AMY1A, AMY1B, AMY1C, AMY2A
RP11-121A8
STARD3NL, AC006033, TRGC2, TRGJ2,
TRGJP2, TRGC1, TRGJ1, TRGJP, TRGJP1,
TRGV11, TRGVB, TRGV10, TRGV9, TRGVA,
TRGV8, TRGV7, TRGV6, TRGV5P, TRGV5
RP11-11M9
RP11-231J7 GRIA2
CTD-2100E13 RIOK3, C18orf8, NPC1, ANKRD29 NPC1 GENE; NPC1
∗ OMIM: Online Mendelian Inheritance in Man.Journal of Biomedicine and Biotechnology 7
TCAG Database. We focused on genes reported in the above
database, although many mRNA were listed in the database
in addition to genes (Table 2).
BAC clone (RP11-90A9) contains two genes: ankyrin
repeat domain 34B (ANKRD34B) and dihydrofolate reduc-
tase (DHFR). A phosphoprotein encoded by ANKRD34B
is induced during bone marrow commitment to dendritic
cells which play an important role in vertebrate immunity
[32]. DHFR genes were reported to be related to various
malignancies including lymphoproliferative disorders such
as systemic non-Hodgkin’s lymphoma, primary central
nervous system lymphoma (PCNSL) [33], and childhood
acutelymphoblastic leukemia[34]. Those two genesare fully
overlapped to the BAC clone (RP11-90A9). It is likely that
the CNVs might aﬀect the copy number of those genes.
One BAC clone (RP11-89B15) contains a gene mes-
enchyme homeobox 2 (MEOX2). The analyses by qPCR
(Figure 3) demonstrated that the copy number of gene
(MEOX2) is deleted in the individual having CNVs detected
by this BAC clone. Loss of MEOX2 gene is associated with
Wilms tumor [35]. MEOX2 induces senescence through
controlling INK4a activity [36]. MEOX2 suppressed epithe-
lial cell proliferation in cooperation with TGF-beta1, and
mediated induction of the cell-cycle inhibitor gene p21
[37]. Finally, the data from genome wide association study
(GWAS) reported that this is one of the candidate genes that
might be associated with ischaemic stroke [38].
Another BAC clone (RP11-115G22) was mapped on the
Chromosomes15.TheBACclonecontainsonegene“cholin-
ergic receptor, nicotinic, alpha 7” (CHRNA7). That gene was
used as a candidate target for examining interactions on
the severity of adult attention deﬁcit hyperactivity disorder
(ADHD) [39]. It is suggested that CHRNA7 regulates
airway epithelium diﬀerentiation by controlling basal cell
proliferation [40]. Moreover, it was reported that the gene is
one of the candidates for Alzheimer’s disease [41]. The gene
CHRNA7 is overlapped to the segmental duplication region
of BAC clone (RP11-115G22). Many CNVs were listed in
the Databases mentioned as above, and those are overlapped
to the gene. For those reasons, our CNV appears to be
overlapped to the genes, and it might aﬀect the copy number
of gene CHRNA7.
A BAC clone (RP11-79O18) contains two genes which
are N-ethylmaleimide-sensitive factor (NSF) and wingless-
type MMTV integration site family, member 3 (WNT3). The
qPCR results (Figure 4) demonstrated that the copy number
of a gene (NSF) increased but no change was observed in
the gene (WNT3). That result suggested that the CNV might
aﬀect the NSF gene, but not the WNT3 g e n e .H o w e v e r ,t h e r e
may be an opportunity for the CNVs to become a surrogate
marker of WNT3 for the future association study between
the CNV and some disease phenotype. The NSF gene is one
of the essential components of membrane fusion machinery
whichisanimportanthomeostaticprocessineukaryoticcells
[42]. The gene also plays an important role for assembly
during human sperm exocytosis [43]. A recent study showed
that the NSF gene is a good candidate marker for association
studies for genetic risk underlying Parkinson’s disease [44].
The WNT3 gene’s single nucleotide polymorphisms (SNPs)
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Figure 3: Characterization of a loss-type CNV detected on a BAC-
clone RP11-89B15. A genome map of the RP11-89B15-containing
region was obtained from the UCSC Genome Browser website. The
distance (bp) from the p-terminalof chromosome7is shownin the
uppermost part. That region contains the gene which is the gene
mesenchyme homeobox2(MEOX2). The positionsofPCR primers
examined are shown by solid boxes. The experimental conditions
are described more precisely in the text. The relative copy number
of each site was normalized using the quantity of the ampliﬁed
s e g m e n to fap o r t i o no fad i ﬀerent chromosome(Chromosome16)
as a standard (relative copy number = 2) and was shownas mean ±
SD (n = 3). The individual (Case A) has variant fragments with a
deletion that contains the 1st exon and 5 -end of the MEOX2 gene.
were used as candidate markers for association studies of
hemorrhagic stroke [45], hypertension [46], and chronic
kidney disease [47]. Upregulation of the WNT gene family,
including WNT3, suggested involvement of the WNT’s
canonical and/or noncanonical signaling pathway in chronic
lymphocytic leukemia [48]. WNT3 signaling is also required
in primary axis formation during vertebrate embryogenesis
[49].
A BAC clone (RP11-79F15) contains two genes: methyl-
CpG binding domain protein 3-like 1 (MBD3L1)a n dc e l l
surface associated mucin 16 (MUC16). MBD3L1 encodes
a protein that is related to methyl-CpG-binding proteins.
The protein is localized to discrete areas in the nucleus,
and expression appears to be restricted to round spermatids,
suggesting that the protein plays a role in the postmeiotic
stages of male germ cell development [50]. On the other
hand, MUC16 is a member of the mucin gene family
and encodes cancer antigen 125 (CA125) which is a blood
biomarker routinely used to monitor the progression of
human epithelial ovarian cancer (EOC), although its poten-
tial role in EOC is poorly understood [51]. Maintenance of
an intact mucosal barrier, one of whose components is a
geneproductofMUC16,iscriticalt opr ev entingdamageand
infection of wet-surfaced epithelia [52]. As we demonstrated
by Southern blot analysis (Figure 1), the polymorphism was
caused by segmental duplications in the BAC clone. The
series of segmental duplicationswere on the 5 -region of two8 Journal of Biomedicine and Biotechnology
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Figure 4: Characterization of a gain-type CNV detected on a BAC-clone RP11-79O18. A genome map of the RP11-79O18-containing
region was obtained from the UCSC Genome Browser website. The distance (bp) from the p-terminal of chromosome 17 is shown in the
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of the gene NSF was ampliﬁed (×3). However, no copy number change was observed in the region of WNT3.
genes (MBD3L1 and MUC16).T h eC N V sd on o ta ﬀect the
expression pattern of the genes, but these CNVs might be
useful surrogate markers for future studies.
A BACclone(RP11-231J7)containsonegene“glutamate
receptor,ionotropic,(AMPA2).”AMPAsareligand-activated
cation channels that mediate the fast component of excita-
tory postsynaptic currents in neurons of the central nervous
system[53].Sincethesizeofthegene(AMPA2)islargerthan
thatoftheBACclone(RP11-231J7),itislikelythattheCNVs
aﬀect the copy number of the gene.
A BAC clone (CTD-2100F13) contains two genes: RIO
kinase 3 (yeast) (RIOK3) and Niemann-Pick disease, type
C1 (NPC1). RIOK3 promotes pancreas ductal cell motility
and invasion in pancreatic cancer [54]. NPC1 can have a
function in the egress of certain membrane-impermeable
lysosomal cargo [55]. The membrane-bound NPC1 and
soluble NPC2 play an important role for the release of
cholesterol from lysosomes. As a result of that mechanism,
the gene is associated with obesity [56–58]. The BAC clone
(CTD-2100F13) is fully overlapped to both of the two genes
(RIOK3 and NPC1) .T h es i z eo fC N V ss u m m a r i z e di nt h e
databases shows that the reported CNVs were overlapped
to both genes. We assumed that our CNVs may reﬂect the
change of copy number of the genes themselves.
Since the genes mentioned are good candidate markers
for enabling us to examine the etiology of common diseases
and phenotypical heterogeneities among individuals, our
highly polymorphic CNVs should be able to become good
markers in future studies.
5.FuturePlans
We are currently planning to examine the same population
using a high-density oligo-array platform to accumulate
more CNV data for Japanese. The reason, as mentioned
before, is that the BAC platform and oligo methods comple-
ment each other. The oligo platform is known to be more
eﬀective in detecting smaller CNVs (around a few kilobases),
even though this approach is less eﬀective in tracing CNVs
in genomic regions of complex structure that are covered
by the BAC approach conducted in this study. We expect
to construct a more deﬁnite Japanese CNV database by the
combination of BAC- and oligo-platform arrays.
6.Conclusion
We conducted population screening for 213 unrelated
Japanese, and observed 680 highly polymorphic CNVs. TheJournal of Biomedicine and Biotechnology 9
majority of the polymorphic CNVs presented on BAC clones
that overlapped with regions of segmental duplication, and
had been previously reported in other publications. Some
CNVs contained genes which might be related to phenotypic
heterogeneity among individuals. Moreover, it is expected
thattheCNVsmightbegoodsurrogatemarkersfordetecting
etiological genes, even if CNVs did not directly aﬀect the
genes themselves.
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